During the past decade, Covance Clinical Research Unit Inc. conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 13 clinical trials were completed, i.e. on average, 14.8% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 9 clinical trials were completed. i.e. 19.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covance Clinical Research Unit Inc." #1 sponsor was "Eli Lilly and Company" with 16 trials, followed by "Bristol-Myers Squibb" with 9 trials sponsored, "Celgene" with 8 trials sponsored, "Amgen" with 6 trials sponsored and "Pfizer" with 6 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covance Clinical Research Unit Inc." #1 collaborator was "Covance" with 5 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 4 trials as a collaborator, "Department of Health and Human Services" with 2 trials as a collaborator, "Altavant Sciences, Inc." with 1 trials as a collaborator and "Alturas Analytics, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Covance Clinical Research Unit Inc." are "Healthy" (41 trials), "Healthy Volunteers" (22 trials), "Healthy Participants" (7 trials), "Healthy Subjects" (6 trials) and "Healthy Volunteer" (4 trials). Many other conditions were trialed in "Covance Clinical Research Unit Inc." in a lesser frequency.

Most popular intervention types in "Covance Clinical Research Unit Inc." are "Drug" (119 trials), "Biological" (5 trials), "Radiation" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "CC-220" (3 trials), "AMG 510" (2 trials), "EDP-305" (2 trials) and "HemaMax" (2 trials). Other intervention names were less common.

The vast majority of trials in "Covance Clinical Research Unit Inc." are 68 trials for "Male" genders, 51 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Covance Clinical Research Unit Inc.". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 116 completed trials in Covance Clinical Research Unit Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Covance Clinical Research Unit Inc., 120 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".